Comparative Pharmacology
Head-to-head clinical analysis: ADRENALIN versus SUS PHRINE SULFITE FREE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADRENALIN versus SUS PHRINE SULFITE FREE.
ADRENALIN vs SUS-PHRINE SULFITE FREE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha-1 activation causes vasoconstriction, beta-1 activation increases heart rate and contractility, beta-2 activation causes bronchodilation.
Epinephrine is a sympathomimetic catecholamine that acts as a non-selective agonist at all adrenergic receptors (α1, α2, β1, β2, β3). Its primary therapeutic effects include vasoconstriction (α1-mediated), bronchodilation (β2-mediated), and positive chronotropic/inotropic effects (β1-mediated).
1 mg (1 mL of 1:1000 solution) intramuscularly or subcutaneously every 5-20 minutes as needed; for cardiac arrest: 1 mg intravenously or intraosseously every 3-5 minutes.
0.3-0.5 mg subcutaneously or intramuscularly every 15-20 minutes as needed for anaphylaxis. Maximum single dose: 0.5 mg.
None Documented
None Documented
Approximately 2-3 minutes for the parent drug in plasma; clinical effects are short-lived due to rapid uptake and metabolism. In severe shock or hepatic impairment, half-life may be slightly prolonged.
2 minutes (initial rapid phase), terminal half-life approximately 1-2 hours (alpha phase). Clinical context: Very short half-life necessitates continuous infusion for sustained effect.
Primarily metabolized in the liver and other tissues by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). Renal excretion of metabolites (metanephrine, vanillylmandelic acid) and unchanged drug (<2% as unchanged). Biliary/fecal excretion is minimal (<5%).
Primarily renal excretion of metabolites (vanillylmandelic acid, metanephrine, and other conjugates); less than 2% excreted unchanged. Minimal biliary/fecal elimination.
Category C
Category C
Adrenergic Agonist
Adrenergic Agonist